The synthetic ligand C-ANP4-23 increases the intracellular cAMP levels in human differentiated adipocytes.
C-ANP4-23 up-regulates the gene and protein expression of GLUT4 and enhances glucose uptake, through AMPK activation.
C-ANP4-23 enhances glucose metabolism and might contribute to the development of new therapies for metabolic diseases.